Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML

Will P. Bultitude, Jennifer Schellekens, Richard M. Szydlo, Chloe Anthias, Sarah A. Cooley, Jeffrey S. Miller, Daniel J. Weisdorf, Bronwen E. Shaw, Chrissy h. Roberts, Christian A. Garcia-Sepulveda, Julia Lee, Rachel M. Pearce, Marie C. Wilson, Michael N. Potter, Jenny L. Byrne, Nigel H. Russell, Stephen MacKinnon, Adrian J. Bloor, Amit Patel, I. Grant McQuakerRam Malladi, Eleni Tholouli, Kim Orchard, Victoria T. Potter, J. Alejandro Madrigal, Neema P. Mayor, Steven G.E. Marsh

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology